Across Medtronic, Siemens Healthineers, Roche, Illumina, GE HealthCare and Abbott, China has driven revenue declines, margin compression, missed targets and – in at least one case – an open acknowledgment that long-term ownership of a China-exposed division may not be the right answer. Picture Courtesy: Shutterstock
